The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Minireview: IGF, Insulin, and Cancer
Open accessAbstract
In recent years, the influence of the IGF system and insulin on cancer growth has been widely studied. Observational human studies have reported increased cancer mortality in those with obesity and type 2 diabetes, which may be attributable to hyperinsulinemia, elevated IGF-I, or potentially both factors. Conversely, those with low insulin, IGF-I and IGF-II levels appear to be relatively protected from cancer development. Initial attention focused on the role of IGF-I in tumor development. The results of these investigations allowed for the development of therapies targeting the IGF-I receptor signaling pathway. However, after in vitro and in vivo studies demonstrating that insulin may also play a significant and independent role in tumorigenesis, insulin is now receiving more attention in this regard. Some studies suggest that targeting insulin receptor signaling may be an important alternative or adjunct to targeting IGF-I receptor signaling. In this minireview, we discuss some of the recent in vitro, animal, and clinical studies that have elaborated our understanding of the influence of IGF and insulin on tumorigenesis. These studies have shed more light on the interaction between insulin and IGF signaling in cancer cells. They have made possible the development of novel targeted therapies and highlighted some of the potential future directions for research and therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16044-3 · Cited by 1,697
Pathophysiology of insulin resistance in human disease
Reaven, G. M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.473 · Cited by 1,226
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0001 · Cited by 1,005
Self-citationNew Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., & Vigneri, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3278 · Cited by 902
Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults
Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J., & Thun, M. J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh161 · Cited by 795
Guevara-Aguirre, J., Balasubramanian, P., Guevara-Aguirre, M., Wei, M., Madia, F., Cheng, C.-W., Hwang, D., Martin-Montalvo, A., Saavedra, J., Ingles, S., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001845 · Cited by 743
Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739
(2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70095-4 · Cited by 652
Hemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., & Sawicki, P. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1418-4 · Cited by 607
Sell, C., Dumenil, G., Deveaud, C., Miura, M., Coppola, D., DeAngelis, T., Rubin, R., Efstratiadis, A., & Baserga, R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3604 · Cited by 538
Alimova, I. N., Liu, B., Fan, Z., Edgerton, S. M., Dillon, T., Lind, S. E., & Thor, A. D. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7933 · Cited by 523
Dunn, S. E., Kari, F. W., French, J. E., Leininger, J. R., Travlos, G. S., Wilson, R., & Barrett, J. C. (1997) · PubMed · Cited by 438
Disruption of insulin–like growth factor 2 imprinting in Beckwith–Wiedemann syndrome
Weksberg, R., Ren Shen, D., Ling Fei, Y., Li Song, Q., & Squire, J. (1993) · Nature Genetics · doi:10.1038/ng1093-143 · Cited by 424
Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues
Scott, J., Cowell, J., Robertson, M. E., Priestley, L. M., Wadey, R., Hopkins, B., Pritchard, J., Bell, G. I., Rall, L. B., Graham, C. F., et al. (1985) · Nature · doi:10.1038/317260a0 · Cited by 412
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
Wu, Y., Yakar, S., Zhao, L., Hennighausen, L. G., & LeRoith, D. (2002) · PubMed · Cited by 380
Self-citationFree insulin-like growth factors in human obesity
Frystyk, J., Vestbo, E., Skjærbaek, C., Mogensen, C. E., & Ørskov, H. (1995) · Metabolism · doi:10.1016/0026-0495(95)90219-8 · Cited by 353
Turner, B. C., Haffty, B. G., Narayanan, L., Yuan, J., Havre, P. A., Gumbs, A. A., Kaplan, L., Burgaud, J., Carter, D., Baserga, R., et al. (1997) · PubMed · Cited by 342
Olmos, D., Postel-Vinay, S., Molife, L. R., Okuno, S. H., Schuetze, S. M., Paccagnella, M. L., Batzel, G. N., Yin, D., Pritchard-Jones, K., Judson, I., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70354-7 · Cited by 340
Elevated insulin receptor content in human breast cancer
Papa, V, Pezzino, V, Costantino, A., Belfiore, A., Giuffrida, D., Frittitta, L., Vannelli, G. B., Brand, R., Goldfine, I. D., & Vigneri, R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114868 · Cited by 338
Coordination and communication between the p53 and IGF-1–AKT–TOR signal transduction pathways
Levine, A. J., Feng, Z., Mak, T. W., You, H., & Jin, S. (2006) · Genes & Development · doi:10.1101/gad.1363206 · Cited by 321
Novosyadlyy, R., Lann, D. E., Vijayakumar, A., Rowzee, A., Lazzarino, D. A., Fierz, Y., Carboni, J. M., Gottardis, M. M., Pennisi, P. A., Molinolo, A. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2141 · Cited by 282
Self-citationRinaldi, S., Cleveland, R., Norat, T., Biessy, C., Rohrmann, S., Linseisen, J., Boeing, H., Pischon, T., Panico, S., Agnoli, C., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.24927 · Cited by 244
Ulanet, D. B., Ludwig, D. L., Kahn, C. R., & Hanahan, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914076107 · Cited by 235
Buck, E., Gokhale, P. C., Koujak, S., Brown, E., Eyzaguirre, A., Tao, N., Rosenfeld-Franklin, M., Lerner, L., Chiu, M. I., Wild, R., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0318 · Cited by 216
Function of the IGF-I Receptor in Breast Cancer
Surmacz, E. (2000) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009523501499 · Cited by 214
Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies
Steuerman, R., Shevah, O., & Laron, Z. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0859 · Cited by 213
Amiel, S. A., Sherwin, R. S., Hintz, R. L., Gertner, J. M., Press, C. M., & Tamborlane, W. V. (1984) · Diabetes · doi:10.2337/diab.33.12.1175 · Cited by 202
Wu, Y., Cui, K. Y., Miyoshi, K., Hennighausen, L. G., Green, J. E., Setser, J., LeRoith, D., & Yakar, S. (2003) · PubMed · Cited by 201
Self-citationYakar, S., LeRoith, D., & Brodt, P. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.010 · Cited by 200
Self-citationZhang, H., Pelzer, A. M., Kiang, D. T., & Yee, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1712 · Cited by 162
Masur, K., Vetter, C., Hinz, A., Tomas, N. M., Henrich, H., Niggemann, B., & Zänker, K. S. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6606050 · Cited by 156
Schernhammer, E. S., Holly, J. M. P., Hunter, D. J., Pollak, M., & Hankinson, S. E. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01149 · Cited by 137
Murphy, S. K., Huang, Z., Wen, Y., Spillman, M. A., Whitaker, R. S., Simel, L. R., Nichols, T. D., Marks, J. R., & Berchuck, A. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0138 · Cited by 136
Acromegaly: Re-thinking the cancer risk
Loeper, S., & Ezzat, S. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9063-z · Cited by 128
Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
Gao, J., Chesebrough, J. W., Cartlidge, S. A., Ricketts, S., Incognito, L., Veldman-Jones, M. H., Blakey, D. C., Tabrizi, M. A., Jallal, B., Trail, P. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2274 · Cited by 124
Wang, Y. Z., & Wong, Y. C. (1998) · The Prostate · Cited by 123
Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation
Zhang, H., Fagan, D. H., Zeng, X., Freeman, K. T., Sachdev, D., & Yee, D. (2010) · Oncogene · doi:10.1038/onc.2010.17 · Cited by 120
Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression
Fierz, Y., Novosyadlyy, R., Vijayakumar, A., Yakar, S., & LeRoith, D. (2009) · Diabetes · doi:10.2337/db09-1291 · Cited by 93
Self-citationSerum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly.
Grinspoon, S. K., Clemmons, D. R., Swearingen, B., et al. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7533774 · Cited by 82
Insulin-Like Growth Factor-I and Cancer Mortality in Older Men
Major, J. M., Laughlin, G. A., Kritz‐Silverstein, D. C., Wingard, D. L., & Barrett-Connor, E. L. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1378 · Cited by 76
Shen, M., Lin, A.-C., Hsu, Y.-M., Chang, T.-J., Tang, M., Alper, S. L., Ellory, J. C., & Chou, C.-Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406706200 · Cited by 76
Paracrine Overexpression of Insulin-Like Growth Factor-1 Enhances Mammary Tumorigenesis in Vivo
de Ostrovich, K. K., Lambertz, I. U., Colby, J. K., Tian, J., Rundhaug, J. E., Johnston, D. A., Conti, C. J., DiGiovanni, J., & Fuchs‐Young, R. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071005 · Cited by 74
Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer
Tamimi, R. M., Colditz, G. A., Wang, Y., Collins, L. C., Hu, R., ROSNER, B. A., Irie, H. Y., Connolly, J. L., & Schnitt, S. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1313-1 · Cited by 73
Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer
Yf, H., Shen, M.-R., Hsu, K.-F., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604661 · Cited by 52
CIGOLINI, M., Seidell, J. C., Targher, G., Deslypère, J. P., Ellsinger, B. M., Charzewska, J., Cruz, A., & Björntorp, P. A. (1995) · Metabolism · doi:10.1016/0026-0495(95)90286-4 · Cited by 47
Dinchuk, J. E., Cao, C., Huang, F., Reeves, K. A., Wang, J., Myers, F., Cantor, G. H., Zhou, X., Attar, R. M., Gottardis, M. M., et al. (2010) · Endocrinology · doi:10.1210/en.2010-0032 · Cited by 42
Singh, S. K., Tan, Q., Brito, C. J., et al. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2009.12.002 · Cited by 39
Yehezkel, E., Weinstein, D., Simon, M., Sarfstein, R., Laron, Z., & Werner, H. (2010) · Diabetologia · doi:10.1007/s00125-010-1899-1 · Cited by 37
Insulin and Diabetes-In Retrospect and in Prospect: The Banting Memorial Lecture, 1945.
BEST, C. H. (1945) · PubMed · Cited by 2
Cited by
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Pollak, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3215 · Cited by 1,116
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Baffy, G., Brunt, E. M., & Caldwell, S. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.027 · Cited by 858
Obesity, Inflammation, and Cancer
Deng, T., Lyon, C. J., Bergin, S., Caligiuri, M. A., & Hsueh, W. A. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044359 · Cited by 794
Teprotumumab for Thyroid-Associated Ophthalmopathy
Smith, T. J., Kahaly, G. J., Ezra, D. G., Fleming, J. C., Dailey, R. A., Tang, R. A., Harris, G. J., Antonelli, A., Salvi, M., Goldberg, R. A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614949 · Cited by 756
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
Hopkins, B. D., Pauli, C., Du, X., Wang, D. G., Li, X., Wu, D., Amadiume, S. C., Goncalves, M. D., Hodakoski, C., Lundquist, M. R., et al. (2018) · Nature · doi:10.1038/s41586-018-0343-4 · Cited by 706
Metadata
- Authors
- Gallagher, E. J., & LeRoith, D.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2011-05-03
- Volume
- 152
- Issue
- 7
- Pages
- 2546-2551
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2150037154
- Cited by
- 349
- References
- 54
- FWCI
- 31.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.